Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington’s disease model in rats

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Metabolic brain disease

• Publication date

  2016-12-08

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11011-016-9929-4PMID 27928694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RUTIN ATTENUATES 3-NITROPROPIONIC ACID INDUCED BEHAVIOURAL ALTERATIONS AND MITOCHONDRIAL DYSFUNCTION IN THE STRIATUM OF RAT BRAIN

  2015cited by this paper
• Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.

  2011cited by this paper
• Protection of fibroblasts (NIH-3T3) against oxidative damage by cyanidin-3-rhamnoglucoside isolated from fig fruits (Ficus carica L.).

  2010cited by this paper
• The effects of rutin on the development of pentylenetetrazole kindling and memory retrieval in rats.

  2010cited by this paper
• Possible role of vitamin E, coenzyme Q10 and rutin in protection against cerebral ischemia/reperfusion injury in irradiated rats

  2010cited by this paper
• Rutin protects the neural damage induced by transient focal ischemia in rats.

  2009cited by this paper
• Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats.

  2009cited by this paper
• Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide.

  2009cited by this paper
• Rutin Supplementation in the Diet has Protective Effects Against Toxicant-Induced Hippocampal Injury by Suppression of Microglial Activation and Pro-Inflammatory Cytokines

  2009cited by this paper
• Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.

  2009cited by this paper
• Selenium: biochemical role as a component of glutathione peroxidase.

  2009cited by this paper
• Protective effect of rutin against spatial memory impairment induced by trimethyltin in rats.

  2008cited by this paper
• Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity.

  2008cited by this paper
• Anticonvulsive effects of intracerebroventricular administration of rutin in rats.

  2008cited by this paper
• Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches

  2007cited by this paper
• Protective effect of rutin, a polyphenolic flavonoid against haloperidol‐induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes

  2007cited by this paper
• Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala.

  2006cited by this paper
• Antioxidant activities and anthocyanin content of fresh fruits of common fig (Ficus carica L.).

  2006cited by this paper
• Antioxidant flavonol glycosides in mulberry (Morus alba L.) leaves isolated based on LDL antioxidant activity

  2006cited by this paper
• Central nervous system depressant action of flavonoid glycosides.

  2006cited by this paper
• Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease.

  2006cited by this paper
• The effect of flavonoids on rat heart mitochondrial function.

  2006cited by this paper
• Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats.

  2006cited by this paper
• Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.

  2006cited by this paper
• Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues

  2006cited by this paper
• Expression pattern of apoptosis-related markers in Huntington’s disease

  2005cited by this paper
• Differential Effects of Buckwheat and Kudingcha Extract on Neuronal Damage in Cultured Hippocampal Neurons and Spatial Memory Impairment Induced by Scopolamine in an Eight-Arm Radial Maze

  2005cited by this paper
• Metabolic and Pharmacological Properties of Rutin, a Dietary Quercetin Glycoside, for Treatment of Inflammatory Bowel Disease

  2005cited by this paper
• Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease.

  2004cited by this paper
• Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease.

  2003cited by this paper
• Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury.

  2003cited by this paper
• Microglial activation and cell death induced by the mitochondrial toxin 3-nitropropionic acid: in vitro and in vivo studies.

  2003cited by this paper
• Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats.

  2003cited by this paper
• Orphenadrine prevents 3‐nitropropionic acid‐induced neurotoxicity in vitro and in vivo

  2001cited by this paper
• Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology.

  2001cited by this paper
• Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation.

  2001cited by this paper
• Naturally occurring polyphenolic antioxidants modulate IgE‐mediated mast cell activation

  2000cited by this paper
• Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

  2000cited by this paper
• Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions.

  2000cited by this paper
• Oxidative Stress in Huntington's Disease

  1999cited by this paper
• 3‐Nitropropionic acid induces a spectrum of Huntington’s disease‐like neuropathology in rat striatum

  1999cited by this paper
• A novel effect of nicotine on mood and sleep in major depression

  1998cited by this paper
• Oral administration of rutoside can ameliorate inflammatory bowel disease in rats.

  1998cited by this paper
• 3‐Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration

  1998cited by this paper
• Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death.

  1997cited by this paper
• Chronic 3-Nitropropionic Acid Treatment in Baboons Replicates the Cognitive and Motor Deficits of Huntington’s Disease

  1996cited by this paper
• Lipid peroxidation in rats intoxicated with 3-nitropropionic acid.

  1995cited by this paper
• Systemic 3-nitropropionic acid: long-term effects on locomotor behavior.

  1994cited by this paper
• NMDA-dependent superoxide production and neurotoxicity

  1993cited by this paper
• Age‐Dependent Vulnerability of the Striatum to the Mitochondrial Toxin 3‐Nitropropionic Acid

  1993cited by this paper
• Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

  1993cited by this paper
• 3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin

  1991cited by this paper
• [Effect of rutin and esculamine on models of aseptic inflammation].

  1986cited by this paper
• Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

  1982cited by this paper
• Huntington's disease: Changes in striatal proteins reflect astrocytic gliosis

  1982cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

  1979cited by this paper
• Inactivation of succinate dehydrogenase by 3-nitropropionate.

  1979cited by this paper
• Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver.

  1979cited by this paper
• Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

  1974cited by this paper
• Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase.

  1974cited by this paper
• Selenium: Biochemical Role as a Component of Glutathione Peroxidase

  1973cited by this paper
• Colorimetric assay of catalase.

  1972cited by this paper
• Purification and properties of glutathione reductase of human erythrocytes.

  1969cited by this paper
• PURIFICATION AND PROPERTIES OF GLUTATHIONE REDUCTASE OF HUMAN ERYTHROCYTES.

  1963cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The Neuroprotective Effects of Agomelatine in a 3‑Nitropropionic Acid-Induced Rat Model of Huntington's Disease via Brain-Derived Neurotrophic Factor (BDNF)/tropomyosin-Related Kinase Receptor Type B (TrKB)/Phosphoinositide 3‑Kinase (PI3K)/Protein Kinase B (AKT) Activation and Rho-Associated Protein

  2026cites this paper
• From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3‐ Nitropropionic Acid‐Induced Huntington's Disease

  2026cites this paper
• Neuroprotection by canagliflozin in a Huntington's disease model: role of HIF-1α and PI3K/AKT signaling.

  2025cites this paper
• Citrus Phytochemicals in Neurodegenerative Diseases: Preclinical Evidence and Clinical Potential

  2025cites this paper
• Neuroprotective effects of candesartan in 3-nitropropionic acid-induced Huntington’s disease: modulation of angiotensin and CREB/BDNF/PGC1-α signaling

  2025cites this paper
• Potential repurposing of lapatinib and pazopanib as neuroprotective agents in a rat model of Huntington’s disease

  2025cites this paper
• Management and Prevention of Neurodegenerative Disorders: Can Antioxidant-Rich Dietary Interventions Help?

  2025cites this paper
• Rutin prevents memory impairment by reducing brain oxidative stress and fungal burden in a rat model of cryptococcosis

  2025cites this paper
• Flavonoids and their role in oxidative stress, inflammation, and human diseases.

  2025cites this paper
• Systemic Neuroprotection by Chlorogenic Acid: Antioxidant and Anti-inflammatory Evaluation in Early Neurodegeneration Induced by 3-Nitropropionic Acid in Mice

  2025cites this paper
• Strawberry and Drupe Fruit Wines Antioxidant Activity and Protective Effect Against Induced Oxidative Stress in Rat Synaptosomes

  2025cites this paper
• Azilsartan Attenuates 3-Nitropropinoic Acid-Induced Neurotoxicity in Rats: The Role of IĸB/NF-ĸB and KEAP1/Nrf2 Signaling Pathways

  2024cites this paper
• Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats.

  2024cites this paper
• Ideal animal models according to multifaceted mechanisms and peculiarities in neurological disorders: present and challenges

  2024cites this paper
• Cilostazol Counteracts Mitochondrial Dysfunction in Hepatic Encephalopathy Rat Model: Insights into the role of cAMP/AMPK/SIRT1/ PINK-1/Parkin hub and p-CREB /BDNF/ TrkB neuroprotective trajectory.

  2024cites this paper
• Hepatoprotective and neuroprotective effects of quinacrine against bile duct ligation-induced hepatic encephalopathy in rats: Role of bone morphogenetic proteins signaling.

  2024cites this paper
• The potential therapeutic role of Lisinopril in augmenting the striatal neuroplasticity via the striatal ACE2/Ang1-7/MAS receptor axis in 3-nitropropionic acid-induced Huntington’s disease in rats: shifting paradigms in Huntington’s disease treatment

  2024cites this paper
• Parthenolide ameliorates 3-nitropropionic acid-induced Huntington’s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting

  2024cites this paper
• Saroglitazar, a PPAR α/γ agonist alleviates 3-Nitropropionic acid induced neurotoxicity in rats: Unveiling the underlying mechanisms.

  2024cites this paper
• Mingjing granule inhibits the subretinal fibrovascular membrane of two-stage laser-induced neovascular age-related macular degeneration in rats

  2024cites this paper
• A novel arylpiperazine derivative (LQFM181) protects against neurotoxicity induced by 3- nitropropionic acid in in vitro and in vivo models.

  2024cites this paper
• Neuroprotective effects of rutin against cuprizone-induced multiple sclerosis in mice

  2024cites this paper
• Activation of alpha-7 nicotinic acetylcholine receptor by tropisetron mitigates 3-nitropropionic acid-induced Huntington's disease in rats: Role of PI3K/Akt and JAK2/NF-κB signaling pathways.

  2024cites this paper
• Oxidative stress, the blood–brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants

  2023cites this paper
• Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs)

  2023cites this paper
• An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development

  2023cites this paper
• Oxidative Stress and Antioxidants in Neurodegenerative Disorders

  2023cites this paper
• Current Trends in Natural Products for the Treatment and Management of Dementia: Computational to Clinical Studies.

  2023cites this paper
• Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease

  2023cites this paper
• Scientific Advances in the Last Decade on the Recovery, Characterization, and Functionality of Bioactive Compounds from the Araticum Fruit (Annona crassiflora Mart.)

  2023cites this paper
• Animal models of Huntington’s disease and their applicability to novel drug discovery and development

  2023cites this paper
• Mitochondrial dysfunction, oxidative stress, ER stress and mitochondria-ER crosstalk alterations in a chemical rat model of Huntington's disease: potential benefits of bezafibrate.

  2023cites this paper
• Toxicity of Copper and Zinc alone and in combination in Caenorhabditis elegans model of Huntington's disease and protective effects of rutin.

  2023cites this paper
• Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington’s disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms

  2023cites this paper
• The function of astrocytes and their role in neurological diseases

  2023cites this paper
• Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington’s disease

  2023cites this paper
• Erythropoietin and Bacillus Calmette-Guérin Vaccination Mitigate 3-Nitropropionic Acid-Induced Huntington-like Disease in Rats by Modulating the PI3K/Akt/mTOR/P70S6K Pathway and Enhancing the Autophagy.

  2022cites this paper
• Harmine prevents 3-nitropropionic acid-induced neurotoxicity in rats via enhancing NRF2-mediated signaling: Involvement of p21 and AMPK.

  2022cites this paper
• RECENT ADVANCES IN ASSESSING THE EFFECTS OF MYCOTOXINS USING ANIMAL MODELS

  2022cites this paper
• Protective effect of rutin against diabetes-associated cognitive decline in rats.

  2022cites this paper
• Behavioral and neurochemical effects in mice after one-generation exposure to low doses of manganese: focus on offspring development.

  2021cites this paper
• C60 Fullerene Reduces 3-Nitropropionic Acid-Induced Oxidative Stress Disorders and Mitochondrial Dysfunction in Rats by Modulation of p53, Bcl-2 and Nrf2 Targeted Proteins

  2021cites this paper
• Neuroprotective effects of rutin on ASH neurons in Caenorhabditis elegans model of Huntington’s disease

  2021cites this paper
• Inhibition of Brain GTP Cyclohydrolase I Attenuates 3-Nitropropionic Acid-Induced Striatal Toxicity: Involvement of Mas Receptor/PI3k/Akt/CREB/ BDNF Axis

  2021cites this paper
• Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia

  2021cites this paper
• Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington’s disease like symptoms in rats

  2021cites this paper
• Mechanistic new insights of flavonols on neurodegenerative diseases.

  2021cites this paper
• Nano-ivabradine averts behavioral anomalies in Huntington's disease rat model via modulating Rhes/m-tor pathway.

  2021cites this paper
• Rutin protects boar sperm from cryodamage via enhancing the antioxidative defense.

  2020cites this paper
• The Beneficial Role of Natural Antioxidants in Alleviating Neuroinflammatory Disorders Including Neurodegeneration

  2020cites this paper
• Recent advances and possibilities for the use of plant phenolic compounds to manage ageing-related diseases

  2020cites this paper
• Chrysin ameliorates 3 nitropropinoic acid induced neurotoxicity targeting behavioural, biochemical and histological alterations

  2020cites this paper
• Artemisia annua, a Traditional Plant Brought to Light

  2020cites this paper
• Ruta graveolens as a potential source of neuroactive compounds to promote and restore neural functions

  2020cites this paper
• Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?

  2020cites this paper
• Dietary Flavonoids in the Management of Huntington’s Disease: Mechanism and Clinical Perspective

  2020cites this paper
• Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease

  2020influential citation
• Piperine mitigates behavioral impairments and provides neuroprotection against 3-nitropropinoic acid-induced Huntington disease-like symptoms

  2020cites this paper
• Rutin protects Huntington's disease through the insulin/IGF1 (IIS) signaling pathway and autophagy activity: Study in Caenorhabditis elegans model.

  2020cites this paper
• Vildagliptin Attenuates Huntington’s Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model

  2019cites this paper
• Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington’s Disease

  2019cites this paper
• The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases

  2019cites this paper
• The role of rutin and diosmin, two citrus polyhydroxyflavones in disease prevention and treatment

  2019influential citation
• Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications

  2019cites this paper
• Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review

  2019cites this paper
• Rutin as neuroprotective agent: from bench to bedside.

  2019cites this paper
• Cytotoxicity Models of Huntington's Disease and Relevance of Hormetic Mechanisms: A Critical Assessment of Experimental Approaches and Strategies.

  2019cites this paper
• Effects of nutritional state, aging and high chronic intake of sucrose on brain protein synthesis in rats: modulation of it by rutin and other micronutrients.

  2018cites this paper
• Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders

  2018cites this paper
• Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation

  2018cites this paper